“New Horizons and Challenges in Translational and Applied Cardiovascular Science”
The program includes 7 sessions that will open with invited Keynote lectures by world leaders in their respective fields and followed by oral presentations that will be selected from submitted abstracts.
Session 1: NEXT GENERATION VASCULAR GRAFTS
Keynote 1: Toshiharu Shinoka (Nationwide Children Hospital, Ohio, USA)
“Toward next generation of tissue engineered vascular grafts for pediatric heart surgery"
Keynote 2: Nicolas L’Heureux (Université de Bordeaux)
“Tissue engineering a completely biological and human vessel”.
Session 2: BIOMECHANICS IN VASCULAR BIOLOGY AND CARDIOVASCULAR DISEASE
Keynote 1: Jolanda Wentzel (Erasmus Medical Center, Rotterdam, The Netherland)
“The role of shear stress in atherosclerotic plaque progression and destabilization in coronary arteries”
Session 3: ATHEROSCLEROSIS AND VASCULAR REMODELING: FROM BIOLOGY TO CLINICAL TRANSLATION
Session 4: CELL-BASED AND OTHER BIOLOGICAL VASCULAR THERAPIES
"Pluripotent stem cells in the clinics: the ESCORT trial and beyond"
Session 5: INFECTION AND VASCULAR BIOMATERIALS
“Management of vascular prosthesis infection: Current standards and future challenges "
Session 6: CURING HEART VALVE DISEASE: MERGING CLINICAL, BIOLOGICAL AND ENGINEERING PERSPECTIVES
“Heart valve tissue engineering: Challenges and future outlook"
Keynote 2: Hanneke Takkenberg, (Erasmus University, Rotterdam, Netherlands
"What is the added value of TE heart valves? Physician, patient and societal perspective”
Session 7: APPLIED CARDIOVASCULAR BIOLOGY IN INDUSTRY: TRANSLATING INNOVATION INTO NEW PATIENT THERAPIES
Keynote 1: Chritian Latrémouille (CARMAT S.A., France / Hôpital Européen Georges Pompidou, Paris)>
"Total Carmat bioprosthetic artificial heart, where do we come from and where we are?"
Keynote 2: Martijn Cox (XELTIS B.V., Eindhoven, The Netherlands)>
"Restorative heart valves: towards clinical application"